首页 正文

Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson's disease

{{output}}
Parkinson's disease (PD) has long been considered an appropriate candidate for cell replacement therapy. We generated high-purity dopaminergic progenitors (A9-DPCs) from human embryonic stem cells and evaluated their safety and exploratory efficacy in a singl... ...